David H. Kreling

1.5k total citations
73 papers, 1.2k citations indexed

About

David H. Kreling is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Pharmacology. According to data from OpenAlex, David H. Kreling has authored 73 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Geriatrics and Gerontology, 32 papers in Economics and Econometrics and 16 papers in Pharmacology. Recurrent topics in David H. Kreling's work include Pharmaceutical Practices and Patient Outcomes (36 papers), Pharmaceutical Economics and Policy (17 papers) and Healthcare Policy and Management (15 papers). David H. Kreling is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (36 papers), Pharmaceutical Economics and Policy (17 papers) and Healthcare Policy and Management (15 papers). David H. Kreling collaborates with scholars based in United States, Taiwan and Czechia. David H. Kreling's co-authors include David A. Mott, Jon C. Schommer, William R. Doucette, Caroline A. Gaither, Craig A. Pedersen, Adrienne Faerber, Betty Chewning, Meg Wise, Amy Kind and Korey A. Kennelty and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Medical Care.

In The Last Decade

David H. Kreling

71 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David H. Kreling United States 17 561 379 378 214 183 73 1.2k
Katherine K. Knapp United States 21 747 1.3× 195 0.5× 345 0.9× 384 1.8× 139 0.8× 59 1.2k
Helene Levens Lipton United States 17 473 0.8× 391 1.0× 225 0.6× 153 0.7× 167 0.9× 36 1.0k
Matthew Perri United States 18 445 0.8× 372 1.0× 242 0.6× 114 0.5× 281 1.5× 64 1.4k
Anandi V. Law United States 22 534 1.0× 208 0.5× 411 1.1× 314 1.5× 229 1.3× 75 1.6k
Marie A. Chisholm‐Burns United States 19 880 1.6× 309 0.8× 340 0.9× 398 1.9× 367 2.0× 47 1.6k
Betty Chaar Australia 23 554 1.0× 317 0.8× 485 1.3× 486 2.3× 94 0.5× 116 1.6k
Caroline A. Gaither United States 26 801 1.4× 370 1.0× 769 2.0× 382 1.8× 188 1.0× 87 1.9k
Joyce Adair Bird United States 21 459 0.8× 298 0.8× 545 1.4× 247 1.2× 137 0.7× 27 1.9k
Afonso Cavaco Portugal 20 377 0.7× 152 0.4× 511 1.4× 249 1.2× 171 0.9× 114 1.5k
Shane P. Desselle United States 22 695 1.2× 182 0.5× 604 1.6× 506 2.4× 103 0.6× 158 1.8k

Countries citing papers authored by David H. Kreling

Since Specialization
Citations

This map shows the geographic impact of David H. Kreling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Kreling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Kreling more than expected).

Fields of papers citing papers by David H. Kreling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Kreling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Kreling. The network helps show where David H. Kreling may publish in the future.

Co-authorship network of co-authors of David H. Kreling

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Kreling. A scholar is included among the top collaborators of David H. Kreling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Kreling. David H. Kreling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mott, David A., Vibhuti Arya, William R. Doucette, et al.. (2024). Association of the COVID-19 Pandemic on Employment Status Change for Practicing Pharmacists. Journal of the American Pharmacists Association. 64(5). 102187–102187.
2.
Arya, Vibhuti, Caroline A. Gaither, David H. Kreling, et al.. (2023). Identifying Services Provided in Community Pharmacy Practice Settings. SHILAP Revista de lepidopterología. 14(3). 2–2. 4 indexed citations
3.
Snyder, Margie E., Betty Chewning, David H. Kreling, et al.. (2020). An evaluation of the spread and scale of PatientToc™ from primary care to community pharmacy practice for the collection of patient-reported outcomes: A study protocol. Research in Social and Administrative Pharmacy. 17(2). 466–474. 7 indexed citations
4.
Schommer, Jon C., Caroline A. Gaither, William R. Doucette, David H. Kreling, & David A. Mott. (2018). Associations between Work Activity and Work Setting Categories and Dimensions of Pharmacists’ Quality of Work Life. SHILAP Revista de lepidopterología. 6(3). 62–62. 13 indexed citations
5.
Kreling, David H.. (2016). Pharmacist surplus could be a good thing—eventually. 1 indexed citations
6.
Kreling, David H., et al.. (2016). The Impact of a Pricing Policy Change on Retail Prices of Medicines in Egypt. Value in Health Regional Issues. 10. 14–18. 5 indexed citations
7.
Kreling, David H., et al.. (2014). The Impact Of Direct Price Control On Pharmaceutical Prices In Egypt. Value in Health. 17(3). A19–A20. 2 indexed citations
8.
Faerber, Adrienne & David H. Kreling. (2013). Content Analysis of False and Misleading Claims in Television Advertising for Prescription and Nonprescription Drugs. Journal of General Internal Medicine. 29(1). 110–118. 53 indexed citations
9.
Look, Kevin A., et al.. (2012). Pharmacy Participation and Claim Characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007. Journal of Managed Care Pharmacy. 18(2). 116–128. 10 indexed citations
10.
Look, Kevin A., et al.. (2011). Economic impact of pharmacist-reimbursed drug therapy modification. Journal of the American Pharmacists Association. 51(1). 58–64. 7 indexed citations
11.
Doucette, William R., Caroline A. Gaither, David H. Kreling, et al.. (2011). Organizational factors influencing pharmacy practice change. Research in Social and Administrative Pharmacy. 8(4). 274–284. 60 indexed citations
12.
Schommer, Jon C., Lourdes G. Planas, Kathleen A. Johnson, et al.. (2010). Pharmacist Contributions to the U.S. Health Care System. SHILAP Revista de lepidopterología. 1(1). 9 indexed citations
13.
Mott, David A., Richard R. Cline, David H. Kreling, et al.. (2008). Exploring trends and determinants of pharmacist wage rates: Evidence from the 2000 and 2004 National Pharmacist Workforce survey. Journal of the American Pharmacists Association. 48(5). 586–597. 7 indexed citations
14.
Mott, David A., William R. Doucette, Caroline A. Gaither, et al.. (2006). Pharmacist participation in the workforce. 46(3). 26 indexed citations
15.
Doucette, William R., David H. Kreling, Jon C. Schommer, et al.. (2006). Evaluation of Community Pharmacy Service Mix: Evidence from the 2004 National Pharmacist Workforce Study. Journal of the American Pharmacists Association. 46(3). 348–355. 93 indexed citations
16.
Jambulingam, Thani & David H. Kreling. (1995). Relationship between the Number of Firms and Generic Drug Price Competition. SSRN Electronic Journal. 2 indexed citations
17.
Kreling, David H. & David A. Mott. (1993). The Cost Effectiveness of Drug Utilisation Review in an Outpatient Setting. PharmacoEconomics. 4(6). 414–436. 13 indexed citations
18.
Page, Connie, David H. Kreling, & Ella Mae Matsumura. (1993). Comparison of the mean per unit and ratio estimators under a simple applications-motivated model. Statistics & Probability Letters. 17(2). 97–104. 4 indexed citations
19.
Kreling, David H. & Joseph B. Wiederholt. (1987). Selecting Health Insurance. Journal of Pharmaceutical Marketing & Management. 1(4). 3–18. 4 indexed citations
20.
Kreling, David H., et al.. (1986). Estimating Pharmacy Level Prescription Drug Acquisition Costs for Third-Party Reimbursement. Medical Care. 24(7). 590–600. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine K. Knapp Breakdown of academic impact, for papers by Helene Levens Lipton Breakdown of academic impact, for papers by Matthew Perri Breakdown of academic impact, for papers by Anandi V. Law Breakdown of academic impact, for papers by Marie A. Chisholm‐Burns Breakdown of academic impact, for papers by Betty Chaar Breakdown of academic impact, for papers by Caroline A. Gaither Breakdown of academic impact, for papers by Joyce Adair Bird Breakdown of academic impact, for papers by Afonso Cavaco Breakdown of academic impact, for papers by Shane P. Desselle
Rankless by CCL
2026